ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER
Methods are provided for the adjuvant treatment of operable HER2-positive primary breast cancer in human patients by administration of pertuzumab in addition to chemotherapy and trastuzumab. The methods reduce the risk of recurrence of invasive breast cancer or death for a patient diagnosed with HER...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | Croatian English |
| Published |
29.03.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Methods are provided for the adjuvant treatment of operable HER2-positive primary breast cancer in human patients by administration of pertuzumab in addition to chemotherapy and trastuzumab. The methods reduce the risk of recurrence of invasive breast cancer or death for a patient diagnosed with HER2-positive early breast cancer (eBC) compared to administration of trastuzumab and chemotherapy, without pertuzumab. |
|---|---|
| AbstractList | Methods are provided for the adjuvant treatment of operable HER2-positive primary breast cancer in human patients by administration of pertuzumab in addition to chemotherapy and trastuzumab. The methods reduce the risk of recurrence of invasive breast cancer or death for a patient diagnosed with HER2-positive early breast cancer (eBC) compared to administration of trastuzumab and chemotherapy, without pertuzumab. |
| Author | Ross, Graham Alexander Benyunes, Mark C |
| Author_xml | – fullname: Benyunes, Mark C – fullname: Ross, Graham Alexander |
| BookMark | eNrjYmDJy89L5WQwdHTxCg1z9AtRCAlydQzxdQWy_N0UPFyDjHQD_IM9QzzDXBWcgFLBIQrOjn7OrkE8DKxpiTnFqbxQmptB2c01xNlDN7UgPz61uCAxOTUvtSTeIyjAyMDIxMDAzDIkxNCYOFUA9jwprg |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | ADJUVANTNO LIJEČENJE HER2-POZITIVNOG RAKA DOJKE |
| ExternalDocumentID | HRP20240069TT1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_HRP20240069TT13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Nov 08 04:41:42 EST 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | Croatian English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_HRP20240069TT13 |
| Notes | Application Number: HR2024P000069T |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240329&DB=EPODOC&CC=HR&NR=P20240069T1 |
| ParticipantIDs | epo_espacenet_HRP20240069TT1 |
| PublicationCentury | 2000 |
| PublicationDate | 20240329 |
| PublicationDateYYYYMMDD | 2024-03-29 |
| PublicationDate_xml | – month: 03 year: 2024 text: 20240329 day: 29 |
| PublicationDecade | 2020 |
| PublicationYear | 2024 |
| RelatedCompanies | F. HOFFMANN - LA ROCHE AG Genentech, Inc |
| RelatedCompanies_xml | – name: Genentech, Inc – name: F. HOFFMANN - LA ROCHE AG |
| Score | 3.5282054 |
| Snippet | Methods are provided for the adjuvant treatment of operable HER2-positive primary breast cancer in human patients by administration of pertuzumab in addition... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | ADJUVANT TREATMENT OF HER2-POSITIVE BREAST CANCER |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240329&DB=EPODOC&locale=&CC=HR&NR=P20240069T1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da8IwED_EjW1vm9vYhxuFjb6VpZ_ahzK0H1TBttQovklSWzYGKtqxf3-XoHNPviU5yBf8crnk7ncArwWpDLJgXa3rLJhm2XyBmCO21jFtUqCKsBwiAoVHiRNPrOHMnjXgax8LI3lCfyQ5IiKqQLzX8rxeHx6xAulbuX3jn9i0eo-oF6g761iQy6EBHfS9MEuD1Fd934tzNcm9TAqJ41I0lU7wHt0RcAinfRGWsv6vU6JLOM2wu2V9BY2PTQvO_X3qtRacjXY_3ljcgW97DXovGE6mvYQqNA97VLDwK2mkxGFuaFk6HtDBNFT6KBpTxRc5Z_IbeIlC6scajj3_W-k8zg_zpLp5C83lalnegcIcZneJwaqyIyjSCtdinOsVL029sF3TvIf2sZ4ejosf4ULUhGuV4bahWW--yyfUtTV_lnv0C2PEfZs |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq2K1akDJLbh5tjkEafMgqc2DdFt6K3kVRUhLG_HvOxta66m3ZQdmH_Dt7OzOfAPwkpGlRPKkL_S1PBEUNc0Rc0QVerJKMjQRikZYorAfaO5UGc3VeQO-9rkwNU_oT02OiIjKEO9VfV6vD49YVh1buX1NP7Fr9eZQw-J33jEjl0MH2hoadhRaocmbpuHGfBAbUS0kmk7RVTrBO3aPwcGeDVlayvq_TXEu4DRCdWV1CY2PTRta5r70WhvO_N2PNzZ34NtegTiwRtPZIKAcje0BZSz8XOhwrh1LQhROPOrNbG6IognlTFZzJr6GZ8empivg2Iu_lS7c-DBPKso30CxXZXELXKIlap9IybLoMYq0TFeSNBWXaSGLmarLcge6xzTdHRc_Qcul_ngx9oL3ezhnEhZmJeldaFab7-IB7W6VPtb79Qty7ICO |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ADJUVANT+TREATMENT+OF+HER2-POSITIVE+BREAST+CANCER&rft.inventor=Benyunes%2C+Mark+C&rft.inventor=Ross%2C+Graham+Alexander&rft.date=2024-03-29&rft.externalDBID=T1&rft.externalDocID=HRP20240069TT1 |